Literature DB >> 23436835

Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know.

Kyung Won Kim1, Katherine M Krajewski, Jyothi P Jagannathan, Mizuki Nishino, Atul B Shinagare, Jason L Hornick, Nikhil H Ramaiya.   

Abstract

OBJECTIVE: In this article, we review the role of imaging in cancer of unknown primary site (CUP) diagnosis and management and the utility of immunohistochemistry, serum tumor markers, and molecular profiling in the optimized care of CUP patients.
CONCLUSION: With advances in imaging, pathology, and molecular medicine, the diagnosis and management of CUP have evolved into more personalized and site-specific therapies. A multidisciplinary integrated approach among oncologists, pathologists, and radiologists is extremely important.

Entities:  

Mesh:

Year:  2013        PMID: 23436835      PMCID: PMC3603700          DOI: 10.2214/AJR.12.9363

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  35 in total

1.  Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.

Authors:  Jong-Lyel Roh; Jae Seung Kim; Jeong Hyun Lee; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

Review 2.  Assessment of the treatment response of HCC.

Authors:  Kyung Won Kim; Jeong Min Lee; Byung Ihn Choi
Journal:  Abdom Imaging       Date:  2011-06

3.  Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  K Fizazi; F A Greco; N Pavlidis; G Pentheroudakis
Journal:  Ann Oncol       Date:  2011-09       Impact factor: 32.976

Review 4.  Pathologic evaluation of unknown primary cancer.

Authors:  Karin A Oien
Journal:  Semin Oncol       Date:  2009-02       Impact factor: 4.929

Review 5.  Overview of patient management and future directions in unknown primary carcinoma.

Authors:  Gauri R Varadhachary; F Anthony Greco
Journal:  Semin Oncol       Date:  2009-02       Impact factor: 4.929

Review 6.  Treatment for patients with unknown primary cancer and favorable prognostic factors.

Authors:  John D Hainsworth; Karim Fizazi
Journal:  Semin Oncol       Date:  2009-02       Impact factor: 4.929

7.  Diagnostic value of whole body diffusion weighted imaging for screening primary tumors of patients with metastases.

Authors:  Tai-Fu Gu; Xin-Lan Xiao; Fei Sun; Jian-Hua Yin; Hai Zhao
Journal:  Chin Med Sci J       Date:  2008-09

8.  Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.

Authors:  John D Hainsworth; David R Spigel; Dana S Thompson; Patrick B Murphy; Cassie M Lane; David M Waterhouse; Yuval Naot; F Anthony Greco
Journal:  Oncologist       Date:  2009-12-04

Review 9.  Carcinoma of unknown primary (CUP).

Authors:  Nicholas Pavlidis; Karim Fizazi
Journal:  Crit Rev Oncol Hematol       Date:  2008-11-01       Impact factor: 6.312

10.  Switching benchmarks in cancer of unknown primary: from autopsy to microarray.

Authors:  George Pentheroudakis; Vassilios Golfinopoulos; Nicholas Pavlidis
Journal:  Eur J Cancer       Date:  2007-08-14       Impact factor: 9.162

View more
  11 in total

1.  Factors associated with subcentimeter pulmonary nodule outcomes followed with computed tomography imaging in oncology patients.

Authors:  André Queiroz de Morais; Thiago Pereira Fernandes da Silva; Juliana Cristina Duarte Braga; Diogo Fábio Dias Teixeira; Paula Nicole Vieira Pinto Barbosa; Fábio José Haddad; Jefferson Luiz Gross; Pablo Rydz Pinheiro Santana; Bruno Hochhegger; Edson Marchiori; Marcos Duarte Guimarães
Journal:  Eur J Radiol Open       Date:  2020-09-30

2.  [Structured diagnostics and therapy of the CUP syndrome].

Authors:  H Löffler; K Neben; A Krämer
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

3.  [Cancer of unknown primary. Epidemiology and pathogenesis].

Authors:  H Löffler; K Neben; A Krämer
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

4.  Metastatic melanoma of unknown primary in the temporalis muscle.

Authors:  Marco Dalle Carbonare; Mei Xien Goh; Zainab AlshiekhAli; David Howlett
Journal:  BMJ Case Rep       Date:  2017-10-20

5.  Metastatic Adenocarcinoma of Unknown Origin Presenting as Small Bowel Perforation: A Case Report and Literature Review.

Authors:  Samir Alkabie; Brian Bello; Roberto F Martinez; W Peter Geis; Michael S Ballo
Journal:  J Investig Med High Impact Case Rep       Date:  2015-03-23

6.  Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.

Authors:  Lauren Patterson Cobb; Stephanie Gaillard; Yihong Wang; Ie-Ming Shih; Angeles Alvarez Secord
Journal:  Gynecol Oncol Res Pract       Date:  2015-05-12

7.  Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.

Authors:  Mária Gődény; Zsolt Lengyel; Gábor Polony; Zoltán Takácsi Nagy; Gergely Léránt; Orsolya Zámbó; Éva Remenár; László Tamás; Miklós Kásler
Journal:  Cancer Imaging       Date:  2016-11-04       Impact factor: 3.909

Review 8.  When heat casts a spell on the DNA damage checkpoints.

Authors:  Thomas Turner; Thomas Caspari
Journal:  Open Biol       Date:  2014-03-12       Impact factor: 6.411

9.  An integrated tool for determining the primary origin site of metastatic tumours.

Authors:  Marcos Tadeu Dos Santos; Bruno Feres de Souza; Flavio Mavignier Cárcano; Ramon de Oliveira Vidal; Cristovam Scapulatempo-Neto; Cristiano Ribeiro Viana; Andre Lopes Carvalho
Journal:  J Clin Pathol       Date:  2017-12-16       Impact factor: 3.411

10.  Detection efficiency of 18F-flourodeoxyglucose positron emission tomography/computed tomography for primary tumors in patients with carcinoma of unknown primary.

Authors:  Nosheen Fatima; Maseeh Uz Zaman; Areeba Zaman; Unaiza Zaman; Sidra Zaman; Rabia Tahseen
Journal:  World J Nucl Med       Date:  2019-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.